IP Verse

Process For Concentration Of Antibodies And Therapeutic Products Thereof

Patent No. EP3805248 (titled "Process For Concentration Of Antibodies And Therapeutic Products Thereof") was filed by Genentech on Sep 8, 2005. The application was issued on Jan 18, 2023.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
APP_61203/2024Nov 14, 2024Cohausz & FlorackGeneric
APP_61187/2024Nov 14, 2024Cohausz & FlorackGeneric
UPC_CFI_166/2024Apr 9, 2024Genentech, NovartisProvisional Measures
UPC_CFI_165/2024Apr 9, 2024Genentech, NovartisProvisional Measures

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KILBURN & STRODEOct 18, 2023KILBURN & STRODE
CELLTRIONOct 16, 2023HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3805248

GENENTECH
Application Number
EP20200642A
Filing Date
Sep 8, 2005
Status
Granted And Under Opposition
Dec 16, 2022
Publication Date
Jan 18, 2023
External Links
Slate, Register , Google Patents